STEPHANIE BRIENZO: Open Payments
NPI 1477958288 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 52 payments from 20 companies in 2025. Trend: 2023 $1,938 · 2024 $1,214 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $248 |
| Abbott Laboratories | 6 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $101 |
| Lilly USA, LLC | 5 | $84 |
| PFIZER INC. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Astellas Pharma US Inc | 2 | $44 |
| Corcept Therapeutics | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
Products named: Ozempic, Kerendia, Wegovy, MOUNJARO, PREVNAR 20, SPRAVATO, Veozah, Korlym.
Industry payments across GA — which companies pay providers there.
